In a monumental shift in military health policy, Defense Secretary Pete Hegseth announced a new screening program for "testosterone deficiency" among U.S. troops, asserting it is necessary to ensure service members operate at their "absolute best."

The mandate dictates that annual screenings will be integrated into required medical evaluations for service members aged 30 and older, while those under 30 may volunteer for testing. Hegseth emphasized via social media that any subsequent testosterone replacement therapy would remain strictly voluntary.

This watershed initiative arrives amid broader administrative pushes to expand access to hormone replacement therapies. However, the Pentagon has yet to disclose the specific academic studies or empirical research underpinning this correlation between routine hormonal screening and battlefield readiness.

Critics, including Representative Chrissy Houlahan, have characterized the announcement as influenced by fringe ideologies, questioning whether the policy will equitably extend to servicewomen requiring estrogen-based evaluations during perimenopause. The policy also reignites debates surrounding performance enhancement, following past scrutiny over testosterone use within elite special operations units.

Official Statement Reference:

Defense Secretary Pete Hegseth announces new policy to test troops for low testosterone and offer them hormone replacement therapy to ensure maximum psychological and mental readiness.

— U.S. Department of Defense (@SecDef) July 15, 2026

For comprehensive coverage and ongoing updates regarding this developing national security and health narrative, consult the original Los Angeles Times report.